Related Experiment Video
Updated: Sep 10, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
597
Outcomes of Reinduction With Nadofaragene Firadenovec
Bogdana Schmidt1,2, Joshua J Horns3, Mark D Tyson4
1Huntsman Cancer Institute, Salt Lake City, Utah.
The Journal of Urology
|August 25, 2025
Abstract
No abstract available in PubMed .

